ArticleEvidence-based medicine2011

For type 2 diabetes poorly controlled by metformin monotherapy, the addition of any non-insulin antidiabetic drug reduces HbA1c to a similar extent, but with differing effects on weight and hypoglycaemic risk.

Srikanth BellaryPubMed ↗Publisher ↗

No numbers read from the abstract.